Pcn42 - Efficacy of Third Line Tyrosine Kinase Inhibitors for Treatment of Advanced Gastrointestinal Stromal Tumours: Systematic Review and Meta-Analysis

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.124
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Complementary Activity of Tyrosine Kinase Inhibitors Against Secondary Kit Mutations in Imatinib-Resistant Gastrointestinal Stromal Tumours

British Journal of Cancer
Cancer ResearchOncology
2019English

Correction: Complementary Activity of Tyrosine Kinase Inhibitors Against Secondary Kit Mutations in Imatinib-Resistant Gastrointestinal Stromal Tumours

British Journal of Cancer
Cancer ResearchOncology
2019English

Systematic Review and Meta-Analysis: Efficacy and Safety of Oral Janus Kinase Inhibitors for Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Efficacy and Safety of Angiogenesis Inhibitors in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

Meta-Analysis of EGFR Tyrosine Kinase Inhibitors Compared With Chemotherapy as Second-Line Treatment in Pretreated Advanced Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2014English

Imatinib for the Treatment of Patients With Unresectable and/or Metastatic Gastrointestinal Stromal Tumours: Systematic Review and Economic Evaluation

Health Technology Assessment
MedicineHealth Policy
2005English

Impact of Patient’s Age on Efficacy of Immune Checkpoint Inhibitors in Advanced Cancers: A Systematic Review and Meta-Analysis

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Practical Role of Mutation Analysis for Imatinib Treatment in Patients With Advanced Gastrointestinal Stromal Tumors: A Meta-Analysis

PLoS ONE
Multidisciplinary
2013English

Economic Evaluation of First Line Treatment for Advanced Non Small Cell Lung Cancer Using Tyrosine Kinase Inhibitors in Malaysia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy